Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Medtronic plc
  6. Summary
    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
125.21(c) 123.23(c) 125.54(c) 126.73(c) 125.49(c) Last
3 837 431 5 820 593 4 623 501 3 924 014 3 315 842 Volume
+0.15% -1.58% +1.87% +0.95% -0.98% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 29 982 M - -
Net income 2021 3 720 M - -
Net Debt 2021 21 975 M - -
P/E ratio 2021 45,8x
Yield 2021 1,80%
Sales 2022 33 181 M - -
Net income 2022 5 699 M - -
Net Debt 2022 20 795 M - -
P/E ratio 2022 30,0x
Yield 2022 1,92%
Capitalization 169 B 169 B -
EV / Sales 2021 6,36x
EV / Sales 2022 5,71x
Nbr of Employees 90 000
Free-Float 99,0%
More Financials
Company
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.9%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - vascular diseases and cardiac surgery (18.4%): coronary stents, endoprostheses for aortal pathologies, distal protection... 
More about the company
Ratings of Medtronic plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about MEDTRONIC PLC
10:02aMEDTRONIC  : First Procedure in the World with Medtronic Hugo Robotic-Assisted S..
AQ
09:01aMEDTRONIC  : Announces Real-World Data on InPen™ and Extended Infusion Set..
AQ
07:25aUNITED THERAPEUTICS  : Medtronics Discontinue Development, Sale of Remodulin Imp..
MT
04:51aUnited Therapeutics, Medtronic Stop Efforts to Develop Implantable System for..
DJ
06/22INSIDER TRENDS : Medtronic Insider Converts/Exercises Derivative Security, Sells..
MT
06/22MEDTRONIC  : Receives FDA Expanded Approval for Arctic Front Family of Cardiac C..
AQ
06/22MEDTRONIC  : First Procedure in the World with Medtronic Hugo™ Robotic-Ass..
AQ
06/22Aziyo Says Most or Recalled FiberCel Lot Already Implanted
DJ
06/21MEDTRONIC  : World's First Heart Valve Replacement Using Extended Reality Platfo..
AQ
06/21MEDTRONIC  : Gets Expanded FDA Nod for Cardiac Cryoablation Catheters as Front-L..
MT
06/21MEDTRONIC  : Receives FDA Expanded Approval for Arctic Front™ Family of Ca..
AQ
06/10MEDTRONIC  : Receives FDA Approval For Spinal Cord Stimulation Therapy Device
MT
06/10MEDTRONIC  : Gets FDA Clearance for Spinal Cord Stimulation Therapy Device
MT
06/10MEDTRONIC  : Announces FDA Approval of its Next Generation Recharge-Free Spinal ..
PR
06/08MEDTRONIC  : Goldman Sachs 42nd Annual Health Care Conference
PU
More news
News in other languages on MEDTRONIC PLC
06/04MORNING BRIEFING - Deutschland/Europa -2-
05/28EQS-ADHOC : Aktionärinnen und Aktionäre von Cosmo Pharmaceuticals nehmen an der ..
05/27LATE BRIEFING - Unternehmen und Märkte -2-
05/27Les valeurs à suivre aujourd'hui à Wall Street Jeudi 27 mai 2021
05/27MEDTRONIC bat le consensus, mais les prévisions sont prudentes
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Stock Trading Strategies
MEDTRONIC PLC - 2020
Buying pressure
BUY
More Stock Trading Analysis
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MDT | IE00BTN1Y115 | MarketScreener
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 29
Last Close Price 125,49 $
Average target price 140,48 $
Spread / Average Target 11,9%
EPS Revisions
Managers and Directors
NameTitle
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC7.13%170 503
ABBOTT LABORATORIES1.23%197 156
BECTON, DICKINSON AND COMPANY-4.00%69 890
HOYA CORPORATION4.06%49 121
ALIGN TECHNOLOGY, INC.13.37%47 855
SARTORIUS STEDIM BIOTECH30.12%41 837